Lewellyn Bigelow
National Institutes of Health
3 Papers
48 Citations
Lewellyn Bigelow is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Tryptophan hydroxylase & Oxytocin. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Relative Risk of Attention Deficits in Siblings of Patients With Schizophrenia
Michael F. Egan,Terry E. Goldberg,Tonya Gscheidle,Mary Weirich,Lewellyn Bigelow,Daniel R. Weinberger +5 more
TL;DR: Given the ease of administering the Continuous Performance Test, the use of impaired attention as an intermediate phenotype could increase the power of genetic studies of schizophrenia.
186
Inhibition of compensatory ovarian hypertrophy in the mouse and vole: a comparison of Altschule's pineal extract, pineal indoles, vasopressin, and oxytocin
TL;DR: Preliminary studies in the vole demonstrated that COH occurred and was significantly blocked by melatonin and Altschule's aqueous pineal extract, demonstrating the anti-FSH action by pineal principles in induced ovulators similar to that described above in spontaneous ovulators (mice).
40
Effect of drugs which inhibit tryptophan hydroxylase or dopamine-β-hydroxylase on pinealectomy-induced seizures in parathyroidectomized rats
TL;DR: Results suggested that depressed brain norepinephrine may somehow be related to the seizures in PTX + PX rats, and the administration of a melatonin-free pineal extract had no influence on the convulsive episodes.
8